Abstract
BAG-1 has been identified as a Bcl-2-binding protein that inhibits apoptosis, either alone or in co-operation with Bcl-2. Here we show that BAG-1 inhibits p53- induced apoptosis in the human tumour cell line Saos-2. In contrast, BAG-1 was unable to inhibit the p53-independent pathway induced by apoptin, an apoptosis-inducing protein derived from chicken anaemia virus. Whereas BAG-1 seemed to co-operate with Bcl-2 to repress p53-induced apoptosis, co-expression of these proteins had no inhibitory effect on apoptin-induced apoptosis. Moreover, Bcl-2, and to some extent also BAG-1, paradoxically enhanced the apoptotic activity of apoptin. These results demonstrate that p53 and apoptin induce apoptosis through independent pathways, which are differentially regulated by BAG-1 and Bcl-2.
Similar content being viewed by others
References
Fraser A, Evan G. A license to kill. Cell 1996; 85: 781–784.
White E. Life, death, and the pursuit of apoptosis. Genes Dev 1996; 10: 1–15.
Korsmeyer SJ. Regulators of cell death. Trends in Gen 1995; 11: 101–105.
Wyllie AH. The genetic regulation of apoptosis. Curr Opin Genet Dev 1995; 5: 97–104.
Hengartner MO. Programmed cell death in invertebrates. Curr Opin Genet Dev 1996; 6: 34–38.
Canman CE, Kastan MB. Induction of apoptosis by tumor suppressor genes and oncogenes. Semin Canc Biol 1995; 6: 17–25.
Reed JC. Bcl-2 and the regulation of programmed cell death. J Cell Biol 1994; 124: 1–6.
Craig RW. The bcl-2 gene family. Semin Cancer Biol 1995; 6: 35–43.
Boise LH, Gottschalk AR, Quintans J, Thompson CB. Bcl-2 and Bcl-2-related proteins in apoptosis regulation. Curr Top Microbiol Immunol 1995; 200: 107–121.
Cory S. Regulation of lymphocyte survival by the bcl-2 gene family. Annu Rev Immunol 1995; 13: 513–543.
Takayama S, Sato T, Krajewski S, et al. Cloning and functional analysis of BAG-1: a novel Bcl-2-binding protein with anti-cell death activity. Cell 1995; 80: 279–284.
Wang H-G, Takayama S, Rapp UR, Reed JC. Bcl-2 interacting protein, BAG-1, binds to and activates the kinase Raf-1. Proc Natl Acad Sci USA 1996; 93: 7063–7068.
Kastan MB, Canman CE, Leonard CJ. p53, cell cycle control and apoptosis: implications for cancer. Cancer Metastasis Rev 1995; 14: 3–15.
Vogelstein B, Kinzler KW. p53 function and dysfunction. Cell 1992; 70: 523–526.
Miyashita T, Reed JC. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 1995; 80: 293–299.
Miyashita T, Krajewski S, Krajewska M, et al. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 1994; 9: 1799–1805.
Noteborn MHM, Todd D, Verschueren CAJ, et al. A single chicken anemia virus protein induces apoptosis. J Virol 1994; 68: 346–351.
Zhuang S-M, Landegent JE, Verschueren CAJ, et al. Apoptin, a protein encoded by chicken anemia virus, induces cell death in various human hematologic malignant cells in vitro. Leukemia 1995; 9: S118–S120.
Zhuang S-M, Shvarts A, Van Ormondt H, Jochemsen AG, Van der Eb AJ, Noteborn MHM. Apoptin, a protein derived from chicken anemia virus, induces p53-independent apoptosis in human osteosarcoma cells. Cancer Res 1995; 55: 486–489.
Zhuang S-M, Shvarts A, Jochemsen AG, Van Oorschot AAAM, Van der Eb AJ, Noteborn MHM. Differential sensitivity to Ad5 E1B-21kD and Bcl-2 proteins of apoptin-induced versus p53-induced apoptosis. Carcinogenesis 1995; 16: 2939–2944.
Baker SJ, Markowitz S, Fearon ER, Willson JKV, Vogelstein B. Suppression of human colorectal carcinoma cell growth by wild-type p53. Science 1990; 249: 912–915.
Menke AL, Shvarts A, Riteco N, Van Ham RCA, Van der Eb AJ, Jochemsen AG. Wilms' tumor 1-KTS isoforms induce p53 independent apoptosis that can be partially rescued by expression of the epidermal growth factor receptor or the insulin receptor. Cancer Res 1997; 57: 1353–1363.
Van der Eb AJ, Graham FL. Assay of transforming activity of tumor virus DNA. Meth Enzymol 1980; 65: 826–839.
Van den Heuvel SJL, Van Laar T, Kast WM, Melief CJ, Zantema A, Van der Eb AJ. Association between the cellular p53 and the adenovirus 5 E1B-55kD proteins reduces the oncogenicity of Ad-transformed cells. EMBO J 1990; 9: 2621–2629.
Noteborn MHM, De Boer GF, Van Roozelaar DJ, et al. Characterization of cloned chicken anemia virus DNA that contains all elements for the infectious replication cycle. J Virol 1991; 65: 3131–3139.
Gurney EG, Harrison RO, Fenno J. Monoclonal antibodies against simian virus 40 T antigens: evidence for distinct subclasses of large T antigen and for similarities among nonviral T antigens. J Virol 1980; 34: 752–763.
Danen-van Oorschot AAAM, Fischer DF, Grimbergen J, et al. Apoptin induces apoptosis in human transformed and malignant cells but not in normal cells. Proc Natl Acad Sci USA 1997; 94: 5843–5847.
Krajewski S, Tanaka S, Takayama S, Schibler M, Fenton W, Reed JC. Investigation of the subcellular distribution of the bcl-2 oncoprotein: residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes. Cancer Res 1993; 53: 4701–4714.
Van den Heuvel SJL, Van Laar T, The I, Van der Eb AJ. Large E1B proteins of adenovirus types 5 and 12 have different effects on p53 and distinct roles in cell transformation. J Virol 1993; 67: 5226–5234.
Sabbatini P, Jiayuh L, Levine AJ, White E. Essential role for p53-mediated transcription in E1A-induced apoptosis. Genes & Dev 1995; 9: 2184–2192.
Strasser A, Harris AW, Huang DCS, Krammer PH, Cory S. Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis. EMBO J 1995; 14: 6136–6147.
Tsujimoto Y, Cossman J, Jaffe B, Croce CM. Involvement of the bcl-2 gene in human follicular lymphoma. Science 1985; 228: 1440–1443.
Campos L, Rouault JP, Sabido O, et al. High expression of the bcl-2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapy. Blood 1993; 18: 3091–3096.
Reed JC, Meister L, Tanaka S, et al. Differential expression of bcl-2 proto oncogene in neuroblastoma and other human tumor cell lines of neural origin. Cancer Res 1991; 51: 6529–6538.
McDonnell T, Troncoso P, Brisbay S, et al. Expression of the proto oncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer. Cancer Res 1992; 52: 6940–6944.
Lotem J, Sachs L. Control of apoptosis in hematopoiesis and leukemia by cytokines, tumor suppressor and oncogenes. Leukemia 1996; 10: 925–931.
Reed JC. Regulation of apoptosis by bcl-2 family proteins and its role in cancer and chemoresistance. Curr Opin Oncol 1995; 7: 541–546.
Hooper ML. The role of the p53 and Rb-1 genes in cancer, development and apoptosis. J Cell Sci Suppl 1994; 18: 13–17.
Lowe SW, Bodis S, McClatchey A, et al. p53 status and the efficacy of cancer therapy in vivo. Science 1994; 266: 807–810.
Smith ML, Fornace Jr AJ. Genomic instability and the role of p53 mutations in cancer cells. Cur Op Onc 1995; 7: 69–75.
Hockenberry DM. bcl-2 in cancer, development and apoptosis. J Cell Sci Suppl 1994; 18: 51–55.
Wyllie AH. Apoptosis and the regulation of cell numbers in normal and neoplastic tissues: an overview. Canc Metast Rev 1992; 11: 95–103.
Sachs L, Lotem J. Control of programmed cell death in normal and leukemic cells: new implications for therapy. Blood 1993; 82: 15–21.
Dive C, Wyllie AH. Apoptosis and cancer chemotherapy. In: Hickman JA, Tritton TT, eds. Frontiers in Pharmacology: Cancer Chemotherapy. Oxford, UK: Blackwell Scientific, 1993: 21–56.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Danen-van Oorschot, A.A.A.M., den Hollander, A.I., Takayama, S. et al. BAG-1 inhibits p53-induced but not apoptin-induced apoptosis. Apoptosis 2, 395–402 (1997). https://doi.org/10.1023/A:1026409808732
Issue Date:
DOI: https://doi.org/10.1023/A:1026409808732